Tesamorelin
An FDA-approved GHRH analog that builds lean muscle and reduces visceral belly fat. Tesamorelin is the only FDA-approved GHRH analog — clinically shown to build lean muscle while reducing visceral belly fat by 15-18%. Uses the full 44 amino acid GHRH sequence with a trans-3-hexenoic acid modification for stability. Produces physiological GH pulses that drive both protein synthesis in skeletal muscle and lipolysis in abdominal fat.
Key Characteristics
- Length: 44 amino acids(Full-length GHRH with N-terminal modification.)
- Half-life: ~26–38 minutes(Longer than sermorelin due to the hexenoic acid modification.)
- FDA Status: FDA Approved(Approved in 2010 for reducing excess abdominal fat.)
- Primary Use: Body recomposition(Reduces visceral fat while increasing lean muscle mass via sustained GH elevation.)
Overview
Core Benefits
Key AdvantagesThese are educational summaries of commonly discussed effects in wellness/regenerative contexts, not guarantees.
Tesamorelin Results Timeline
ProgressionTimeline is illustrative and non-guaranteed. Outcomes vary and are commonly discussed alongside training, nutrition, sleep, and cycling practices.
How It WorksGHRH Analog (Growth Hormone Releasing Hormone)
Sequence → Stability → GH Pattern → Outcomes
GHRH Receptor on Pituitary Somatotrophs
Tesamorelin binds the same GHRH receptor as Sermorelin and CJC-1295. However, Tesamorelin uses the full 44 amino acidGHRH sequence rather than just the first 29, providing a more "native-like" signaling profile.
cAMP → PKA Cascade → Reliable GH Pulse
Same cAMP/PKA signaling cascade as other GHRH analogs. The trans-3-hexenoic acid cap at the N-terminus increases stability in the bloodstream, resulting in a more predictable and reliable stimulation window compared to shorter fragments.
Consistent GH Pulses → Fat Loss + Muscle Growth
The reliable GH pulse pattern drives both visceral fat mobilization and lean muscle accrual. Clinical trials showed 15-18% visceral fat reduction alongside increased lean body mass — GH simultaneously upregulates lipolysis in visceral adipocytes and protein synthesis in skeletal muscle.
Body Recomposition → Lean Muscle + Less Belly Fat
Users notice reduced abdominal circumference and increased muscle firmness, typically visible within 2-3 months. Improved energy, better lipid panels, and stronger workouts follow. Tesamorelin has the strongest clinical evidence of any GHRH analog for measurable body composition changes in both directions.
What Makes This Peptide Different
Tesamorelin is the only GHRH analog with FDA approval(for HIV-associated lipodystrophy). It uses the full 44-amino acid GHRH sequence with a trans-3-hexenoic acid modification at the N-terminus. This makes it more "native-like" than the 29-AA fragments ( Sermorelin, CJC-1295) while being more stable than unmodified GHRH. Its clinical validation for both visceral fat reduction and lean mass gains sets it apart from all other GHRH peptides.
Sequence → Why It Matters
Tesamorelin is a nearly full-length GHRH analog with one key modification:
So what? Being a nearly full-length analog with a stability-enhancing cap gives Tesamorelin the most predictable stimulation window among pulsatile GHRH peptides. This reliability is likely why it has the strongest clinical data for measurable body recomposition — both visceral fat reduction and lean muscle gains.
GHRH Peptide Comparison
| Peptide | Half-Life | GH Pattern | What's Unique |
|---|---|---|---|
| Sermorelin | ~10-20 min | Short, natural pulse | Native GHRH(1-29) — unmodified, shortest duration |
| CJC-1295 (no DAC) | ~30 min | Broader natural pulse | 4 substitutions for stability — reliable signaling |
| Tesamorelin | ~26-38 min | Reliable, broader pulse | Full 44-AA + hexenoic acid — FDA-approved, builds lean mass |
| CJC-1295 (DAC) | 6-8 days | Sustained elevation | Albumin binding — weekly dosing, non-pulsatile |
Top Tesamorelin Vendors
Popular Tesamorelin Stacks
Pre-made bundles ranked by value. Cost per mg is based on the Tesamorelin portion of each stack.
Tesamorelin + Ipamorelin
Bundle of Tesamorelin (FDA-approved GHRH analog) and Ipamorelin (ghrelin-receptor secretagogue) for synergistic GH release.
Dosing ProtocolBody Recomposition / Muscle + Fat Loss
Educational reference only. Individual responses vary. Consult healthcare provider before use.
Why This Dosing Protocol
Why 5 days on / 2 days off? Prevents receptor desensitization and maintains consistent response quality across the protocol duration.
Why this works for visceral fat: Consistent GH pulses preferentially mobilize visceral adipose tissue. The reliable half-life means each dose hits the same signaling window, creating cumulative fat mobilization over weeks to months.
Diagrams
Reconstitution Calculator
Dilution math and unit conversions. Prefilled using a common vial size for this peptide.
Open calculatorEducational Videos
How to Reconstitute Peptides
Handling
Educational overview on storage, labeling, and traceability considerations for lab environments. Consult primary literature and vendor documentation for specifics.
- Freezer (-20°C): 1+ year
- Refrigerator (2-8°C): 1-3 months
- Room temperature: 2-3 weeks (emergency only)
- MUST refrigerate at 2-8°C
- 4-week maximum shelf life
- NEVER freeze after reconstitution
- Use bacteriostatic water for multi-dose
Storage & Handling Guide
Learn proper storage temperatures, shelf life timelines, reconstitution best practices, and travel tips for lyophilized and reconstituted peptides.
FAQ
What makes Tesamorelin different from other GHRH peptides?
Tesamorelin is the only GHRH analog that is FDA-approved for a specific therapeutic use (reducing excess abdominal fat). It uses the full 44 amino acid GHRH sequence with a trans-3-hexenoic acid modification, giving it a longer half-life (~26-38 minutes) than sermorelin and making it particularly effective for reducing visceral (abdominal) fat.
What are the most common side effects?
In clinical trials, the most common side effects included injection site reactions (redness, itching, swelling), joint pain (arthralgia), and peripheral edema (fluid retention in extremities). Some patients also reported muscle pain and paresthesia (tingling sensations). These effects are generally mild and often decrease with continued use.
How effective is Tesamorelin for fat loss?
In FDA clinical trials, Tesamorelin reduced trunk fat by approximately 15-18% over 26 weeks. It specifically targets visceral adipose tissue (VAT) rather than subcutaneous fat, making it particularly effective for reducing dangerous abdominal fat associated with metabolic syndrome and cardiovascular risk.
Does Tesamorelin build muscle?
Yes. Tesamorelin stimulates sustained growth hormone release, which drives protein synthesis and lean muscle accrual. Clinical trials showed significant increases in lean body mass alongside visceral fat reduction — making it one of the few peptides clinically demonstrated to shift body composition in both directions simultaneously. The GH elevation also supports faster workout recovery and connective tissue repair, further supporting muscle-building goals.
Is Tesamorelin FDA-approved?
Yes. Tesamorelin was FDA-approved in November 2010 specifically for the reduction of excess abdominal fat. This makes it unique among GHRH peptides as it has undergone rigorous clinical trials and regulatory review for this specific indication.
What is the typical Tesamorelin dosage?
A common research dosage is 1 mg injected subcutaneously once daily (20 units on 1ml syringe). Best taken AM and/or PM on an empty stomach (2+ hour fast). Protocol: 5 days on, 2 days off, 8 weeks on, 8 weeks off. The FDA-approved dose for lipodystrophy is 2 mg daily.
Why does Tesamorelin target visceral fat specifically?
Growth hormone preferentially mobilizes visceral fat (deep abdominal fat around organs) over subcutaneous fat (fat under the skin). Tesamorelin's ability to increase GH levels results in selective reduction of this metabolically dangerous fat. Visceral fat is linked to insulin resistance, cardiovascular disease, and metabolic syndrome.
Can Tesamorelin be combined with other peptides?
Yes, some combine Tesamorelin with GHRPs like Ipamorelin for enhanced GH release. Others add AOD-9604 for additional fat loss effects. Since Tesamorelin is FDA-approved, it has more established safety data than most peptides, making it a foundation some build upon.
How does Tesamorelin compare to Sermorelin and CJC-1295?
Tesamorelin uses the full 44-amino acid GHRH sequence (vs 29 for Sermorelin), has a longer half-life due to its modification, and is FDA-approved. It's specifically proven for visceral fat reduction. Sermorelin and CJC-1295 are more commonly used for general GH benefits. Tesamorelin is typically more expensive but has stronger clinical validation.
How long does reconstituted peptide last?
Once mixed with bacteriostatic water, peptides remain stable for up to 4 weeks when refrigerated at 2-8°C (36-46°F). Unopened powder can last 1+ year in the freezer. Get our complete Storage & Travel Guide.
Is this peptide legal to purchase?
Peptides sold "for research purposes only" are legal to purchase in the US, but are not FDA-approved for human use outside of specific medical applications. Always consult a healthcare provider before use.
New to peptides?
Take our Peptide Match tool to find the best peptide for your goals. You can also read our Complete Guide to Peptides to learn the basics.
Tesamorelin Research Articles
Tesamorelin Dosing: 1mg 5on/2off Protocol
The FDA dose is 2mg — but the cheat sheet runs 1mg 5on/2off. Covers both protocols, cycling, and IGF-1 monitoring.
guidesSermorelin Dosing: 200-300mcg/Day Protocol
The 5-on/2-off schedule prevents the desensitization most people miss. Covers 200-300mcg daily, bedtime timing, and 8-week cycling.
resultsSermorelin Results: Week-by-Week Timeline
IGF-1 rises in 2 weeks, but body composition takes 8-12. Here's exactly when each sermorelin effect kicks in, backed by clinical data.
resultsTesamorelin Results: Week-by-Week Timeline
Most visible changes start at week 8 — but GH levels shift in days. Full tesamorelin timeline from first injection to 6 months.
Scientific Sources
The following peer-reviewed studies and official resources provide additional scientific context for this peptide:
Disclosure: we may earn affiliate commission from qualifying purchases. Educational information only — not medical advice.